OGN vs SAM · P/E 3.4, rev $6.40B vs rev $2.01B
Organon & Co (OGN) versus Boston Beer Company Inc (SAM) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SAM currently screens at market cap $1.79B.
Not investment advice. Open the OGN and SAM stock pages for the full models.
Not investment advice.